As a critical presidential election in the US draws nearer, the Investing News Network asked two fund managers to share their perspectives on the cannabis investment landscape.

The guests were Nawan Butt, portfolio manager at Purpose Investments and co-manager of the Purpose Marijuana Opportunities Fund (NEO:MJJ), and Dan Ahrens, managing director and chief operating officer with AdvisorShares and manager of the AdvisorShares Pure Cannabis ETF (ARCA:YOLO).

To stay ahead and keep their funds performing well, both of the fund managers carefully scan developments in the cannabis market on a day-to-day basis.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ahrens kicked the discussion off by noting that he is still supremely interested in seeing healthy balance sheets and in tracking the path to profitability for cannabis companies. He is excited about the rising division between players that are performing well and those that aren’t.

“Cannabis stocks have traded way too much on hype in the past,” Ahrens said. “In 2020, we’re seeing some real separation between some of the biggest Canadian licensed producers.”

AdvisorShares recently launched a new cannabis exchange-traded fund (ETF) focused entirely on multi-state operators in the US market. It is called the AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) and is also managed by Ahrens.

Ahrens previously shared his frustration with the cannabis investment space, particularly in terms of the lack of awareness on which companies will actually benefit from advancements in the US — a market he is heavily bullish on when it comes to cannabis.

YOLO cannabis etf chart

Six month performance of the AdvisorShares Pure Cannabis ETF.

Ahrens and Butt both share the view that the US market represents the smart money opportunity for investors at the moment, offering a clear distinction in the overall cannabis stock universe.

Beyond the presidential election, the American cannabis market is set to potentially see some catalysts as five states in the country ask voters about introducing cannabis programs. Decisions are pending in Arizona, Mississippi, Montana, New Jersey and South Dakota, and could add momentum for operators.

Butt pointed to New Jersey as a state market that he is watching in particular. Additionally, he praised Arizona as a state with an organized framework with its medical cannabis program and said he is excited by the potential of this market going recreational this year.

Purpose marijuana fund chart

Six month performance of the Purpose Marijuana Opportunities Fund.

In a recent note to investors, Butt, alongside Greg Taylor, his fellow fund manager and the chief investment officer at Purpose Investments, wrote that the upswing for cannabis operations in US state markets will continue with or without federal reform for the industry.

“We continue to see outsized growth in most states as operators have worked out how to optimize within the current constraints,” the pair from Purpose Investments wrote as part of their commentary. “Any reform at the federal level will cause a step function in valuations of these operators, but explosive growth can still continue under current regulations.”

Watch the full video above to hear the entire discussion between Butt and Ahrens.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced Boris Jordan Curaleaf Executive Chairman, will participate in Cantor Fitzgerald’s cannabis focused “Weednesday Series” investor fireside chat on June 30, 2021 at 11:00 am ET .

The event will be hosted by Pablo Zuanic , Managing Director, U.S. Consumer and Cannabis Equity Analyst at Cantor Fitzgerald and will be webcast live. To access the fireside chat webcast, please visit the investor relations section of the Curaleaf website, under the events tab, at .

Keep reading... Show less

Code Investment Love Hemp Announces Major Deal that Will See Anthony Joshua as Brand Ambassador and Collaborator on Licensed Range of CBD Products for Athletes

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s investment, Love Hemp Group Plc. has signed a major endorsement agreement with World Heavyweight Champion, Anthony Joshua, (https:twitter.comanthonyjoshua

Keep reading... Show less

Canbud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“Canbud” or the “Corporation”) is pleased to announce that its subsidiary Empathy Plant Co. has joined Plant-Based Foods of Canada (PBFC).

PBFC was founded in 2018 and has since acted as the collective voice of plant-based food companies. As a division of Food, Health & Consumer Products of Canada (FHCP), they work to keep consumers, governments and industry participants informed about the benefits of plant-based foods. The goal of PBFC is to move regulations forward to support innovation, growth and make plant-based eating more available to the masses.

Keep reading... Show less

 Trulieve Cannabis Corp. (” Trulieve ” or the ” Company “) (CSE: TRUL) (OTC: TCNNF) and Harvest Health & Recreation Inc. (” Harvest “) (CSE: HARV) (OTCQX: HRVSF) today  announced the expiration of the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) in connection with the previously announced proposed acquisition (the “Transaction”).

Trulieve CEO Kim Rivers commented, “Completion of the HSR milestone is exciting and we will continue to work toward closing this strategic transaction. Upon closing, we expect to leverage the expertise and resources of the combined companies to realize meaningful scale and expansion for years to come.”

Keep reading... Show less

Little Green Pharma Ltd (ASX: LGP) has acquired a world-class, fully-operational, GMP medicinal cannabis cultivation and manufacturing facility in Denmark from Canopy Growth Corporation (TSX:WEED, NASDAQ: CGC).

The facility, located in Northern Odense , has the capacity to produce in excess of 12 tonnes per annum of finished flower and provides LGP with much-needed product supply from its current inventory of ~1 tonne of medicinal cannabis flower products.

Keep reading... Show less